• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
0913693 B.C. Ltd
Ammpower Corp
Cabaletta Bio, Inc. - Common Stock
First Trust Smith Opportunistic Fixed Income ETF
Generation Mining Ltd
Lftd Partners Inc
Masterbeat Corp
Paris CAC 40
Patrick Industries, Inc. - Common Stock
Pt Alamtri Res Indonesia Tbk
Quanta AI Inc
Seneca Bancorp Inc
Solstice Advanced Materials Inc. - Common Stock
Tandy Leather Fctry
Tesco Plc ADR
Vivid Seats Inc. - Warrant
Xperi Holding Corporation - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ:SNOA)

1.140 -0.010 (-0.86%)
Delayed Quote Updated: 2:21 PM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,199
Open 1.170
Bid (Size) 1.140 (600)
Ask (Size) 1.170 (100)
Prev. Close 1.150
Today's Range 1.140 - 1.190
52wk Range 0.8501 - 4.100
Shares Outstanding 1,730,613
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
August 06, 2026
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
June 30, 2026
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire

Performance

52-Week Range 72.2% below 52-week high
1.140
0.8552W Low 4.1052W High
1 Week 7.3% below 1-week high
1.101W Low 1.231W High

Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA) traded between $0.85 and $4.10 over the past 52 weeks and last traded at $1.14, 72.2% below its 52-week high. Over the past week it ranged between $1.10 and $1.23.

Past 12 Months
-1.7%
-8.8%
-4.6%
-49.3%
-68.7%
-71.1%
1W -$0.02
1M -$0.11
3M -$0.05
6M -$1.11
YTD -$2.50
1Y -$2.80

SNOA was -71.1% over the past year, -49.3% over six months, -68.7% year to date, -1.7% in the last week.

12 Months vs Market
SNOA
-71.1%
DIA
+12.9%
SPY
+15.4%
QQQ
+18.9%
IWM
+11.7%

Over the past 12 months SNOA returned -71.1% versus DIA (Dow) +12.9%, SPY (S&P 500) +15.4%, QQQ (Nasdaq 100) +18.9% and IWM (Russell 2000) +11.7%.

Volume & Liquidity 0.06× 3-mo avg
Today 6,199 3-mo avg 105.0K
1W
38.1K
1M
40.3K
3M
105.0K
6M
172.7K
YTD
118.5K
1Y
99.9K

SNOA most recently traded 6,199 shares against a 3-month average daily volume of 105.0K.

More News

Read More
News headline image
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
June 16, 2026
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire
Unusual volume stocks are being observed in Tuesday's session. ↗
April 28, 2026
Via Chartmill
Unusual volume stocks in Monday's session ↗
April 27, 2026
Via Chartmill
News headline image
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
April 24, 2026
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
March 24, 2026
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
March 18, 2026
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
February 10, 2026
Via ACCESS Newswire
News headline image
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
November 13, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
November 06, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
November 04, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 14, 2025
Via Benzinga
News headline image
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
October 14, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
October 07, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 25, 2025
Via ACCESS Newswire
News headline image
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
August 26, 2025
Via ACCESS Newswire
News headline image
5 Healthcare Stocks On Fire This Week ↗
August 21, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 15, 2025
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
August 14, 2025
Via Chartmill
News headline image
Which stocks are most active on Thursday? ↗
August 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 14, 2025
Via Benzinga
News headline image
Thursday's session: top gainers and losers ↗
August 14, 2025
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
August 14, 2025
Via Chartmill
News headline image
Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results ↗
August 14, 2025
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Sonoma Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Sonoma Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Sonoma Pharmaceuticals, Inc. - Common Stock trade on?
Sonoma Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock is SNOA on the Nasdaq Stock Market
What is the current price of Sonoma Pharmaceuticals, Inc. - Common Stock?
The current price of Sonoma Pharmaceuticals, Inc. - Common Stock is 1.140
When was Sonoma Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Sonoma Pharmaceuticals, Inc. - Common Stock was at 10/21/26 02:21 PM ET
What is the market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock is 1.97M
How many shares of Sonoma Pharmaceuticals, Inc. - Common Stock are outstanding?
Sonoma Pharmaceuticals, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap